Publications

June 1998
Supplement

MBA Integrative Exercise: General Management, April 1998

By: Carin-Isabel Knoop

Drummond Paris, Regional Pharma Head, Asia/Pacific Novartis AG, discusses the company situation in Indonesia: joint ventures, budget, keeping track, and the prognosis for the future. View Details

Keywords: Business or Company Management; Joint Ventures; Forecasting and Prediction; Pharmaceutical Industry; Indonesia

October 1992 (Revised September 1993)
Case

Nopane Advertising Strategy

By: David E. Bell

Nopane is a proprietary drug that sells in much of the United States. It faces substantial competition. The brand manager is undertaking an experiment to determine whether ad copy should be emotional-based or rational-based. The data and associated regression results... View Details

Keywords: Competition; Intellectual Property; Advertising; Health Care and Treatment; Brands and Branding; Product Marketing; Pharmaceutical Industry; United States

February 1998 (Revised October 1998)
Background Note

Note on New Drug Development in the United States

By: Stefan H. Thomke and Ashok Nimgade

An overview of the new drug development process in the United States, using the migraine drug Imitrex as an illustrative example. View Details

Keywords: Product Development; Research and Development; Health; Pharmaceutical Industry; United States

February 1996 (Revised April 2004)
Case

Eli Lilly and Company: Innovation in Diabetes Care

By: Clayton M. Christensen

Summarizes Eli Lilly's history of innovation in its business, describing how the dimensions along which innovations have been made in the industry have changed. Lilly's innovation strategy has been to pursue ever higher performance products, while others in the... View Details

Keywords: Change; Product; Service Delivery; Product Development; Innovation and Management; Innovation Strategy; Health Care and Treatment; Pharmaceutical Industry

August 1995
Teaching Note

Eli Lilly and Company: The Flexible Facility Decision (1993) TN

By: Gary P. Pisano

Teaching Note for (9-694-074). View Details

Keywords: Pharmaceutical Industry

February 1987 (Revised January 1989)
Case

SmithKline Consumer Products: The Contac Relaunch

In March 1986, a tamperer contaminated CONTAC Cold Capsules, SmithKline Consumer Product's most popular product. To relaunch CONTAC after withdrawing it from the market, the management team had to present a plan of action to the corporation board. They knew CONTAC's 25... View Details

Keywords: Safety; Crisis Management; Product Launch; Pharmaceutical Industry

Find at Harvard

February 1974
Case

Listerine Lozenges

By: Stephen A. Greyser

Keywords: Advertising Campaigns; Pharmaceutical Industry

Find at Harvard

February 1992 (Revised April 1995)
Case

Pfizer: Global Protection of Intellectual Property

By: Lynn S. Paine and Michael Santoro

Top officials at Pfizer are assessing their strategy for improving protection of Pfizer's patents around the world. The outcome of the Uruguay Round of the GATT negotiations is uncertain, and it is not clear whether an acceptable intellectual property protection... View Details

Keywords: Patents; Trade; Policy; Government and Politics; Business Strategy; Agreements and Arrangements; Alliances; Cross-Cultural and Cross-Border Issues; Pharmaceutical Industry; United States; Japan; Europe

August 1990 (Revised March 1991)
Case

Eli Lilly and Co. (C): Japan

By: Michael Y. Yoshino

Describes the process of establishing an independent operation in Japan in the mid-1980s as a result of a decision to make a major investment in the market. Describes the challenges in setting up such an operation and focuses on the role of the country manager in... View Details

Keywords: Business Divisions; Business Startups; Decisions; Investment; Growth Management; Managerial Roles; Markets; Problems and Challenges; Pharmaceutical Industry; Japan

April 1989 (Revised January 1994)
Case

Novo Industri

By: Michael E. Porter and Michael J. Enright

Describes the structure of the insulin industry, a treatment for diabetes and Novo's strategy and competitive position in early 1982. The industry is undergoing significant change and Novo must decide how to defend and build its international position. Designed as an... View Details

Keywords: Change; Global Strategy; Industry Structures; Alliances; Competitive Strategy; Health Disorders; Pharmaceutical Industry